Clinical Impact of Neoadjuvant Therapy for Resectable Pancreatic Ductal Adenocarcinoma: A Single-Center Retrospective Study

Neoadjuvant therapy is recommended for treating resectable pancreatic ductal adenocarcinoma (PDAC); however, its appropriate use in patients with resectable PDAC remains debatable. This study aimed to identify independent poor prognostic factors and evaluate the clinical significance of neoadjuvant...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of surgical oncology 2025-01
Hauptverfasser:	Shimane, Gaku, Kitago, Minoru, Yagi, Hiroshi, Abe, Yuta, Hasegawa, Yasushi, Hori, Shutaro, Tanaka, Masayuki, Tsuzaki, Junya, Yokoyama, Yoichi, Masugi, Yohei, Takemura, Ryo, Kitagawa, Yuko
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!